Hikma Pharmaceuticals PLC announced that Surendera Tyagi, PhD, will join Hikma as Group Chief Scientific Officer and Global Head of Research and Development. Dr. Tyagi will focus on the Group's non-injectables business during the first year and will become a member of Hikma's Executive Committee. Dr. Tyagi joins from Fresenius Kabi, where he most recently led their US Innovation & Development Center.